Skip to main content
. 2019 Apr 8;18:122. doi: 10.1186/s12936-019-2755-5

Fig. 5.

Fig. 5

The relative impact of treatment coverage on case incidence and mortality rates. In the a low (baseline PfPr2-10: 10%) transmission setting increasing treatment coverage leads to reductions in the mortality rate and incidence. In the b medium (baseline PfPr2-10: 30%) and c high (baseline PfPr2-10: 60%) transmission settings increasing treatment coverage is still associated with declines in the mortality rate. However, as transmission increases the impact of increasing treatment coverage on incidence becomes less. For all examples LLIN access is fixed at 25%